These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35328198)

  • 1. PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples.
    Ronchi A; Zito Marino F; Moscarella E; Brancaccio G; Argenziano G; Troiani T; Napolitano S; Franco R; Cozzolino I
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of melanocytic markers for immunocytochemical evaluation of lymph-node melanoma metastases on cytological samples.
    Ronchi A; Zito Marino F; Toni G; Pagliuca F; Russo D; Signoriello G; Moscarella E; Brancaccio G; Argenziano G; Franco R; Cozzolino I
    J Clin Pathol; 2022 Jan; 75(1):45-49. PubMed ID: 33509946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of preferentially expressed antigen in melanoma (PRAME) immunohistochemistry for metastatic melanoma in cytology specimens.
    Saad M; Cantley R; Hao W; Wang Z; Thomas D; Pantanowitz L; Jin X
    Diagn Cytopathol; 2024 Jul; 52(7):362-368. PubMed ID: 38558495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological features of metastatic melanoma in effusion cytology of serosal cavity].
    Xia Q; Chang XN; Huang B; Li XF; Luo DJ; Wang QJ; Jiang MT; Fan J; Zhou DW
    Zhonghua Bing Li Xue Za Zhi; 2024 Aug; 53(8):837-842. PubMed ID: 39103266
    [No Abstract]   [Full Text] [Related]  

  • 5. HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME).
    Grillini M; Ricci C; Pino V; Pedrini S; Fiorentino M; Corti B
    Appl Immunohistochem Mol Morphol; 2022 Jan; 30(1):14-18. PubMed ID: 34508017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Melan-A in cutaneous granular cell tumours: a diagnostic pitfall.
    Van Winden VI; Wong DD; Wood BA; Filion P; Harvey NT
    Pathology; 2024 Feb; 56(1):47-51. PubMed ID: 37989630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRAME/MELAN-A double immunostaining as a diagnostic tool for conjunctival melanocytic lesions: A South American experience.
    Carvajal P; Zoroquiain P
    Pathol Res Pract; 2023 Oct; 250():154776. PubMed ID: 37696245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Sry-Related HMG-Box Gene 10 (SOX10) as a marker of melanoma in effusion cytology.
    Dermawan JKT; Underwood D; Policarpio-Nicolas ML
    Diagn Cytopathol; 2019 Jul; 47(7):653-658. PubMed ID: 30794352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRAME Expression as Helpful Immunohistochemical Marker in Rhabdoid Melanoma.
    Glutsch V; Wobser M; Schilling B; Gesierich A; Goebeler M; Kneitz H
    Dermatopathology (Basel); 2022 May; 9(2):148-157. PubMed ID: 35645230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcomatoid Dedifferentiated Melanoma: The Diagnostic Role of Next-Generation Sequencing.
    Valiga AA; Fuller CG; Doyle JA; Lee JB
    Am J Dermatopathol; 2022 Apr; 44(4):282-286. PubMed ID: 34726188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors.
    Kaczorowski M; Chłopek M; Kruczak A; Ryś J; Lasota J; Miettinen M
    Am J Surg Pathol; 2022 Nov; 46(11):1467-1476. PubMed ID: 35973038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of HMB45 and negative PRAME expression in halo nevi.
    Ruby KN; Li Z; Yan S
    J Cutan Pathol; 2021 Apr; 48(4):519-525. PubMed ID: 33184871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
    Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
    Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of PRAME immunohistochemistry in PEComa family of tumors and morphologic mimics with emphasis on the gynecologic tract.
    Smithgall MC; Liu-Jarin X; Chen X; Singh K; Quddus MR; Cimic A
    Hum Pathol; 2023 Aug; 138():12-17. PubMed ID: 37209921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PReferentially Expressed Antigen in MElanoma (PRAME): preliminary communication on a translational tool able to early detect Oral Malignant Melanoma (OMM).
    Cascardi E; Cazzato G; Ingravallo G; Dellino M; Lupo C; Casatta N; Ballini A; Pacifici A; Marenzi G; Sammartino G; Maiorano E; Tatullo M
    J Cancer; 2023; 14(4):628-633. PubMed ID: 37057287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors.
    Alomari AK; Tharp AW; Umphress B; Kowal RP
    J Cutan Pathol; 2021 Sep; 48(9):1115-1123. PubMed ID: 33660310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRAME expression in 155 cases of metastatic melanoma.
    Gradecki SE; Slingluff CL; Gru AA
    J Cutan Pathol; 2021 Apr; 48(4):479-485. PubMed ID: 32939793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna.
    Gradecki SE; Valdes-Rodriguez R; Wick MR; Gru AA
    Histopathology; 2021 Jun; 78(7):1000-1008. PubMed ID: 33280156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms.
    Googe PB; Flanigan KL; Miedema JR
    Am J Dermatopathol; 2021 Nov; 43(11):794-800. PubMed ID: 33989214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of MiTF staining in undifferentiated pleomorphic sarcoma: caution in the use of melanocytic markers in sarcoma.
    Choy B; Hyjek E; Montag AG; Pytel P; Haydon R; Luu HH; Zhen CJ; Long BC; Kadri S; Segal JP; Furtado LV; Cipriani NA
    Histopathology; 2017 Apr; 70(5):734-745. PubMed ID: 27926791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.